The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders

Gynecological Endocrinology

Volumn 25, Issue 12, 2009, Pages 799-806

  Kostrzak, A ^a   Warenik Szymankiewicz, A ^a   Meczekalski, B ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Hyperprolactinaemia; Macroprolactin; Menstrual disorders; PCOS; PEG precipitation; Prolactinoma

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MACROGOL; PROLACTIN; TESTOSTERONE; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; IMMUNOPRECIPITATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION; MENSTRUATION DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

ADULT; BODY MASS INDEX; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERPROLACTINEMIA; LUTEINIZING HORMONE; MAGNETIC RESONANCE IMAGING; MENSTRUAL CYCLE; OLIGOMENORRHEA; PITUITARY NEOPLASMS; POLYCYSTIC OVARY SYNDROME; PROLACTIN; PROLACTINOMA; TESTOSTERONE; THYROTROPIN;

EID: 70450213741     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903209329     Document Type: Article

References (19)

1. Riddle O, Bates WR, Dykshorn WS. A new hormone of the anterior pituitary. Proc Soc Exp Biol Med 1932;29:1211-1212.
2. Stricker P, Gruter F. Action du lobe anterieur de l'hypophyse sur la montee laiteuse. Comput Soc Biol 1928;99; 1978-1980.
3. Prabhakar VK, Davis JR. Hyperprolactinaemia. Best Pract Res Clin Obstet Gynaecol 2008;22:341-353.
4. Speroff L, Glass R, Kase GN. The breast. Clinical and gynecological endocrinology and infertility. Lippincott Williams & Wilkins, Philadelphia, USA; 1999. pp 595-641.
5. Sinkunas K, Rastenyte D, Deltuva VP, Knispelis R, Tamasauskas A. Transsphenoidal surgery for prolactinomas: Results and prognosis. Medicina (Kanas) 2007;43:691-697.
6. Berinder K, Stackenas I, Akre O, Hirschberg AL, Hulting AL. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol (Oxf) 2005;63:450-455.
7. Beshay VE, Beshay JE. Pituitary tumors: diagnosis, management, and implications for reproduction. Semin Reprod Med 2007;25:388-401.
8. Zosmer A. Polycystic ovary syndrome. N Engl J Med 1996;334:668.
9. Fahie-Wilson. The macroprolactinemia problem and its solution. South Med J 2006;99:1206.
10. Hattori N, Nakayama Y, Kitagawa K, Ishihara T, Saiki Y, Inagaki C. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Clin Endocrinol (Oxf) 2008;68:72-76.
11. Kavanagh-Wright L, Smith TP, Gibney J, McKenna TJ. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clin Endocrinol (Oxf) 2009;70:599-605.
12. Leslie H, Courtney CH, Bell PM, Hadden DR, Macance DR, Eblis PK, Sheridan B, Atkinson AB. Laboratory and clinical experience in 55 patients with macroprolactinemia identifed by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001;86:2743-2746.
13. The Practise Commitee of American Society for Reproductive Medicine. Current evaluation of amenorrhoea. Fertil Steril 2008;90 (Suppl) S219-25.
14. Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
15. Mounier C, Trouillas J, Claustrat B, Duthel R, Estor B. Macroprolactinaemia associated with prolactin adenoma. Hum Reprod 2003;18:853-857.
16. Moran C, Fonseca ME, Ochoa R, Mason M, Gama R, Zarate A. Molecular heterogeneity of prolactin and gonadotropins in some forms of sterility. Ginecol Obstet Mex 1990;58 (Suppl 1):9-13.
17. Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 1985;61:258-264.
18. Fideleff HL, Rubal G, Boquete H, Pujol A, Sequera A, Obrado P. Macroprolactinemia in childhood and adolescence: A cause of asymptomatic hyperprolactinemia. Horm Res 2000;53:16-19.
19. Vilar L, Moura E, Canadas V, Gusmao A, Campos R, Leal E, Teixeira L, Santos V, Gomes B, Lima M, Pai-za R, Alburqueque JL, Egito CS, Botelho CA, Azevedo M, Casulari LA, Naves LA. Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia. Arq Bras Endocrinol Metab 2007;51:86-91.